Jackson Grant Investment Advisers’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-20
Closed -$2.39K 435
2026
Q1
$2.39K Hold
20
﹤0.01% 379
2025
Q4
$2.72K Hold
20
﹤0.01% 375
2025
Q3
$2.95K Hold
20
﹤0.01% 382
2025
Q2
$2.59K Hold
20
﹤0.01% 358
2025
Q1
$2.39K Hold
20
﹤0.01% 353
2024
Q4
$2.32K Hold
20
﹤0.01% 366
2024
Q3
$2.7K Hold
20
﹤0.01% 361
2024
Q2
$2.71K Hold
20
﹤0.01% 354
2024
Q1
$2.58K Hold
20
﹤0.01% 349
2023
Q4
$2.29K Hold
20
﹤0.01% 348
2023
Q3
$1.82K Hold
20
﹤0.01% 353
2023
Q2
$2.25K Hold
20
﹤0.01% 363
2023
Q1
$2.09K Buy
+20
New +$2.09K ﹤0.01% 386

Other funds holding XYL

Jackson Grant Investment Advisers's XYL Position: Q2 2026 in Review

Jackson Grant Investment Advisers sold out of Xylem (XYL) in Q2 2026, closing a stake of 20 shares — an estimated $2.39K sold.

Jackson Grant Investment Advisers first reported a position in XYL in Q1 2023 and held it in 13 quarters. The position peaked at $2.95K in Q3 2025. 1,098 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Jackson Grant Investment Advisers reported no remaining Xylem position as of Q2 2026 after selling out during the quarter.
  • Jackson Grant Investment Advisers sold 20 Xylem shares in Q2 2026, an estimated $2.39K.
  • Jackson Grant Investment Advisers first reported a position in Xylem in Q1 2023 and held it in 13 quarters.
  • Jackson Grant Investment Advisers's Xylem position peaked at $2.95K in Q3 2025.
  • 1,098 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Jackson Grant Investment Advisers's 13F filing for Q2 2026, filed 31 Jul 2026.